Showing 320 businesses for "Pharmaceuticals"
Businesses
BIOGEN INC.
Biogen is a biotechnology company focused on developing and delivering innovative therapies for neurological and neurodegenerative diseases. They offer a wide range of medicines and therapies, including treatments for Alzheimer's disease, multiple sclerosis, and spinal muscular atrophy. Biogen is a leader in research and development of new treatments for serious diseases.
Cingulate Inc.
Cingulate is a clinical-stage biopharmaceutical company developing innovative treatments for Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety disorders. They utilize their Precision Timed Release™ (PTR™) drug delivery platform to create next-generation pharmaceutical products. Their focus is on improving the lives of patients suffering from conditions needing burdensome daily dosing regimens. Cingulate's pipeline includes CTx-1301, CTx-1302 (ADHD), and CTX-2103 (anxiety).
Telix Pharmaceuticals Ltd
Telix is a global, commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals. They deliver precision medicine through targeted radiation for cancer and rare diseases. Their lead product, Illuccix®, is approved for use in the United States and Australia. Telix has an extensive pipeline in urologic, neurologic and musculoskeletal oncology.
CATALYST PHARMACEUTICALS, INC.
Catalyst Pharmaceuticals is dedicated to improving the lives of patients with rare diseases. They focus on developing and commercializing innovative therapies. The company is positioned as a leader in the treatment of rare neuromuscular diseases.
VERTEX PHARMACEUTICALS INC / MA
Vertex is a global biotechnology company focused on discovering, developing, and commercializing innovative medicines. They are known for their significant advancements in treating cystic fibrosis (CF) with CFTR modulators. Vertex also has a pipeline targeting other serious diseases in areas such as pain, kidney diseases, sickle cell disease, beta thalassemia, and type 1 diabetes, positioning them as a leader in addressing unmet medical needs.
Laboratorios Farmaceuticos Rovi, S.A./ADR
ROVI is a pharmaceutical company focused on the research, development, manufacturing, and marketing of specialty pharmaceuticals. Their key products include low molecular weight heparin and biosimilars. The company has a significant international presence and a strong commitment to research and development.
Valneva SE
Valneva is a specialty vaccine company focused on developing, manufacturing, and commercializing prophylactic vaccines for infectious diseases with unmet medical needs. They offer commercially available vaccines like a single-shot chikungunya vaccine, and boast a robust pipeline of vaccine candidates, including those against Lyme disease, Shigella, and Zika. With expertise in travel health and a commitment to innovation, Valneva aims to prevent suffering from vaccine-preventable diseases. The company has over 700 employees in six countries.
CEVA INC
Ceva is the 5th largest global animal health company, led by experienced veterinarians. They provide innovative health solutions for all animals to ensure the highest level of care and well-being. As a leading French company headquartered in France, Ceva focuses on 'One Health' and sustainable practices. Their vision emphasizes the interconnectedness of human, animal, and planetary health.
MOLECULAR PARTNERS AG
Molecular Partners is a pioneering biopharmaceutical company focused on DARPin therapeutics, a new class of custom-built drugs. They develop innovative therapies for serious diseases, including cancer. Their strategy combines in-house DARPin design and development expertise with collaborations to deliver a broad pipeline.
Harmony Biosciences Holdings, Inc.
Harmony Biosciences focuses on developing and delivering innovative treatments for rare neurological diseases. They offer medicines for sleep/wake disorders, neurobehavioral issues, and rare epilepsies. The company is committed to improving the lives of patients through research and a strong focus on patient needs.
COLLEGIUM PHARMACEUTICAL, INC
Collegium Pharmaceutical is a biopharmaceutical company dedicated to improving the lives of individuals living with serious medical conditions. They focus on developing differentiated medications, with a strong presence in responsible pain management and neuropsychiatry, including a medicine for ADHD. Collegium is committed to building a leading, diversified portfolio and contributing to the well-being of their communities.
Xeris Biopharma Holdings, Inc.
Xeris is a biopharmaceutical company focused on developing and commercializing innovative products to improve patient lives across a range of therapies. They offer ready-to-use solutions across various therapeutic areas. The company is known for its advanced products and partnerships.
BAYER AS
Bayer is a company committed to "Health for All, Hunger for None." They develop innovative medicines and strive for an improved food supply. In Norway, Bayer concentrates on research and development of radiopharmaceuticals, particularly cancer therapeutics using alpha-emitting isotopes. They developed the oncology drug Xofigo.
Terns Pharmaceuticals, Inc.
Terns is a clinical-stage biopharmaceutical company developing superior therapies to elevate human health. They focus on small molecule medicines targeting diseases with significant unmet medical needs, particularly in oncology. Their aim is to create transformative medicines through bold innovation and clinically validated mechanisms.
PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company that discovers, develops, and commercializes clinically differentiated medicines for children and adults living with serious diseases of high unmet need. Focused on rare diseases with a patient-centric approach, PTC combines scientific expertise with groundbreaking technology. Key research areas include splicing modulation and inflammation & ferroptosis, aiming to provide broad access to life-changing treatments.
Sarepta Therapeutics, Inc.
Sarepta Therapeutics is a global biotechnology company focused on precision genetic medicine for rare diseases. They engineer RNA platforms and gene therapy to transform genetic understanding into medicine. Sarepta strives to accelerate the development of new treatments, building the world's largest gene therapy manufacturing capacity.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals is a commercial-stage biopharmaceutical company focused on cardiovascular diseases. They are FDA-approved for treating acute episodes of PSVT with CARDAMYST™ and are developing etripamil for AFib-RVR. The company is dedicated to developing self-administered treatment solutions to improve the lives of people living with episodic cardiovascular conditions.
SHIONOGI & CO LTD
Shionogi is a pharmaceutical company focused on research and development to provide novel treatments, particularly for infectious diseases. They are committed to addressing antimicrobial resistance (AMR) and improving access to healthcare. Shionogi develops innovative therapies and promotes the proper use of medicines, striving to enhance affordability and accessibility worldwide.
Septerna, Inc.
Septerna is a biotechnology company powered by its proprietary Native Complex Platform™ to develop oral small molecule therapies targeting GPCRs. The company focuses on treating patients in endocrinology, immunology and inflammation, and metabolic diseases, with a deep pipeline of product candidates.
INOVIO PHARMACEUTICALS, INC.
INOVIO is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer, and infectious diseases. They are trailblazers in the DNA medicine field, working to commercialize innovative, next-generation medicines. Their focus is on innovating medicine to help save lives.